ARMP

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Armata Pharmaceuticals Inc

NYSE MKT | ARMP

5.65

USD

$0.00

(

0.00%

)

At Close (As of Nov 6, 2025)

$205.06M

Market Cap

-

P/E Ratio

-1.07

EPS

$7.10

52 Week High

$0.90

52 Week Low

HEALTHCARE

Sector

ARMP Chart

Recent Chart
Price Action

ARMP Technicals

Tags:

ARMP Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.8M
Total Revenue $5.2M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$42M
Selling General And Administrative $13M
Research And Development $34M
Operating Expenses $48M
Investment Income Net -
Net Interest Income -$10M
Interest Income $697K
Interest Expense $11M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$8.2M
Ebitda -$6.8M
Net Income -$19M

Revenue & Profitability

Earnings Performance

ARMP Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $86M
Total Current Assets $11M
Cash And Cash Equivalents At Carrying Value $9.3M
Cash And Short Term Investments $9.3M
Inventory -
Current Net Receivables $744K
Total Non Current Assets $75M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $10M
Intangible Assets Excluding Goodwill $10M
Goodwill $3.5M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.3M
Other Non Current Assets -
Total Liabilities $134M
Total Current Liabilities $48M
Current Accounts Payable $766K
Deferred Revenue -
Current Debt -
Short Term Debt $43M
Total Non Current Liabilities $86M
Capital Lease Obligations $32M
Long Term Debt $55M
Current Long Term Debt $39M
Long Term Debt Noncurrent -
Short Long Term Debt Total $127M
Other Current Liabilities $4.1M
Other Non Current Liabilities -
Total Shareholder Equity -$48M
Treasury Stock -
Retained Earnings -$328M
Common Stock $362K
Common Stock Shares Outstanding $59M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$38M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.3M
Capital Expenditures $1.9M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1.9M
Cashflow From Financing $35M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$19M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.8M
Total Revenue $5.2M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$42M
Selling General And Administrative $13M
Research And Development $34M
Operating Expenses $48M
Investment Income Net -
Net Interest Income -$10M
Interest Income $697K
Interest Expense $11M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$8.2M
Ebitda -$6.8M
Net Income -$19M

ARMP Profile

Armata Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Armata Pharmaceuticals Inc. is a clinical-stage biotechnology company based in Marina del Rey, California, focused on developing innovative bacteriophage-based therapies to tackle the escalating threat of antibiotic-resistant infections. By harnessing advanced technologies and deep research expertise, Armata aims to deliver precision medicine solutions that address urgent needs in infectious disease management. The company is building a robust pipeline of therapeutic candidates and establishing strategic collaborations, positioning itself as a key player in the critical fight against antimicrobial resistance and enhancing treatment options for patients worldwide.

WORX
+39.10%
$0.40
ASST
+0.08%
$1.46
EZGO
+59.26%
$0.23
NVDA
-2.95%
$189.43
BYND
-3.48%
$1.22
CHR
-15.40%
$0.06
SNAP
+12.33%
$8.20
MTC
+25.33%
$2.77
VHAI
0.00%
$0.00
TSLA
-3.69%
$444.98
PFE
+0.87%
$24.82
PLUG
+4.76%
$2.64
SOFI
-9.01%
$27.35
RIVN
-0.48%
$15.34
YDKG
+1.17%
$0.05
STGW
+17.87%
$5.67
DNN
-2.99%
$2.59
NIO
-1.64%
$7.17
AXDX
-61.36%
$0.03
AMD
-7.26%
$237.70
WTO
-5.84%
$0.04
ONDS
-10.91%
$5.34
PLTR
-5.76%
$177.06
AAL
-2.01%
$13.15
FTEL
-23.88%
$1.68
F
+0.83%
$13.21
BITF
-8.75%
$3.70
T
+0.49%
$24.56
INTC
-2.07%
$37.58
BURU
-8.77%
$0.26
ADAP
-15.14%
$0.05
ACHR
-6.86%
$8.91
CIFR
-13.29%
$21.42
BTG
-5.70%
$3.80
ETHD
+8.59%
$4.86
HOOD
-10.84%
$127.02
KVUE
+1.69%
$16.50
IONZ
-7.62%
$3.81
IREN
-11.35%
$67.73
NUAI
+9.17%
$6.19
HIMS
-5.07%
$41.51
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BTBT
-6.85%
$3.05
NVO
+0.43%
$48.46
GPUS
-1.76%
$0.38
BAC
+2.24%
$53.63
GRAB
+1.15%
$5.70
RGTI
-5.60%
$35.20
XPEV
+10.99%
$24.18
CELH
-25.80%
$44.46
SRM
+53.27%
$10.30
SOUN
-8.01%
$14.46
QBTS
-7.46%
$28.70
BMNR
-9.48%
$37.49
WBD
-1.51%
$22.41
EOSE
+3.57%
$15.39
NOK
+1.24%
$6.93
PGHL
+13.94%
$0.52
RXRX
-5.11%
$4.70
HTZ
-0.81%
$6.67
CMG
+0.72%
$31.97
MARA
-4.69%
$16.32
RIG
-1.02%
$3.86
AAPL
+0.36%
$271.12
AMCR
+1.79%
$8.21
HL
+13.74%
$13.77
JOBY
-3.40%
$14.49
AMZN
-2.03%
$245.12
PLTZ
+11.83%
$6.97
TLRY
-4.68%
$1.22
WLGS
-5.57%
$0.04
DVLT
-12.50%
$1.40
LYFT
+7.70%
$21.62
CAN
-12.01%
$1.13
VALE
-0.77%
$12.21
IONQ
+3.41%
$57.30
ZJYL
+3.52%
$0.25
GOOGL
+0.42%
$285.51
ACVA
-37.54%
$5.09
HPE
+0.63%
$23.71
GGB
+5.26%
$3.60
ETWO
0.00%
$3.30
WULF
-4.02%
$14.74
PLTD
+1.41%
$6.44
PINS
+5.53%
$27.17
KMX
-25.60%
$30.36
BBD
-0.42%
$3.51
CCC
-2.93%
$7.61
ABEV
-0.20%
$2.41
EPWK
-0.28%
$0.06
ITUB
+0.20%
$7.49
MU
+1.35%
$240.72
BTE
+0.84%
$2.39
NGD
+3.38%
$7.03
SLDP
-20.65%
$6.75
EQX
+8.16%
$11.46
MRVL
+0.67%
$93.52
DFLI
-18.58%
$0.88
DKNG
+1.30%
$28.28
WORX
+39.10%
$0.40
ASST
+0.08%
$1.46
EZGO
+59.26%
$0.23
NVDA
-2.95%
$189.43
BYND
-3.48%
$1.22
CHR
-15.40%
$0.06
SNAP
+12.33%
$8.20
MTC
+25.33%
$2.77
VHAI
0.00%
$0.00
TSLA
-3.69%
$444.98
PFE
+0.87%
$24.82
PLUG
+4.76%
$2.64
SOFI
-9.01%
$27.35
RIVN
-0.48%
$15.34
YDKG
+1.17%
$0.05
STGW
+17.87%
$5.67
DNN
-2.99%
$2.59
NIO
-1.64%
$7.17
AXDX
-61.36%
$0.03
AMD
-7.26%
$237.70
WTO
-5.84%
$0.04
ONDS
-10.91%
$5.34
PLTR
-5.76%
$177.06
AAL
-2.01%
$13.15
FTEL
-23.88%
$1.68
F
+0.83%
$13.21
BITF
-8.75%
$3.70
T
+0.49%
$24.56
INTC
-2.07%
$37.58
BURU
-8.77%
$0.26
ADAP
-15.14%
$0.05
ACHR
-6.86%
$8.91
CIFR
-13.29%
$21.42
BTG
-5.70%
$3.80
ETHD
+8.59%
$4.86
HOOD
-10.84%
$127.02
KVUE
+1.69%
$16.50
IONZ
-7.62%
$3.81
IREN
-11.35%
$67.73
NUAI
+9.17%
$6.19
HIMS
-5.07%
$41.51
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BTBT
-6.85%
$3.05
NVO
+0.43%
$48.46
GPUS
-1.76%
$0.38
BAC
+2.24%
$53.63
GRAB
+1.15%
$5.70
RGTI
-5.60%
$35.20
XPEV
+10.99%
$24.18
CELH
-25.80%
$44.46
SRM
+53.27%
$10.30
SOUN
-8.01%
$14.46
QBTS
-7.46%
$28.70
BMNR
-9.48%
$37.49
WBD
-1.51%
$22.41
EOSE
+3.57%
$15.39
NOK
+1.24%
$6.93
PGHL
+13.94%
$0.52
RXRX
-5.11%
$4.70
HTZ
-0.81%
$6.67
CMG
+0.72%
$31.97
MARA
-4.69%
$16.32
RIG
-1.02%
$3.86
AAPL
+0.36%
$271.12
AMCR
+1.79%
$8.21
HL
+13.74%
$13.77
JOBY
-3.40%
$14.49
AMZN
-2.03%
$245.12
PLTZ
+11.83%
$6.97
TLRY
-4.68%
$1.22
WLGS
-5.57%
$0.04
DVLT
-12.50%
$1.40
LYFT
+7.70%
$21.62
CAN
-12.01%
$1.13
VALE
-0.77%
$12.21
IONQ
+3.41%
$57.30
ZJYL
+3.52%
$0.25
GOOGL
+0.42%
$285.51
ACVA
-37.54%
$5.09
HPE
+0.63%
$23.71
GGB
+5.26%
$3.60
ETWO
0.00%
$3.30
WULF
-4.02%
$14.74
PLTD
+1.41%
$6.44
PINS
+5.53%
$27.17
KMX
-25.60%
$30.36
BBD
-0.42%
$3.51
CCC
-2.93%
$7.61
ABEV
-0.20%
$2.41
EPWK
-0.28%
$0.06
ITUB
+0.20%
$7.49
MU
+1.35%
$240.72
BTE
+0.84%
$2.39
NGD
+3.38%
$7.03
SLDP
-20.65%
$6.75
EQX
+8.16%
$11.46
MRVL
+0.67%
$93.52
DFLI
-18.58%
$0.88
DKNG
+1.30%
$28.28
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.